¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´ ´ëÇѺ´¸®ÇÐȸ 2018³âµµ Á¦3Â÷ ¿¬¼ö±³À° (¼Òȱ⺴¸®) : 2018-12-01 ±³À°ÀÏÀÚ : 2018-12-01 ±³À°Àå¼Ò : ¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø Àº¸í´ë°´ç ±³À°ÁÖÁ¦ : 2018³âµµ Á¦3Â÷ ¿¬¼ö±³À° (¼Òȱ⺴¸®) ÁÖÃÖ±â°ü : ´ëÇѺ´¸®ÇÐȸ ´ã´çÀÚ : ´ëÇѺ´¸®ÇÐȸ ¿¬¶ôó : 02-795-3094 À̸ÞÀÏ : kspjamoon@kams.or.kr ±³À°Á¾·ù : º´¸®°ú Âü¼®¿¹»óÀοø : 200¸í Èñ¸ÁÆòÁ¡ : 5Á¡ Áö¿ª : ¼¿ïƯº°½Ã ±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ ¼¼ºÎ¼ö°·á : 110,000¿ø ºñ°í 1. ȸ¿ø 1) ¹Ì³³È¸ºñ ¾ø´Â °æ¿ì »çÀüµî·Ï Àü¹®ÀÇ 50,000 Àü°øÀÇ30,000 ÇöÀåµî·Ï Àü¹®ÀÇ 60,000 Àü°øÀÇ40,000 2) ¹Ì³³È¸ºñ ÀÖ´Â °æ¿ì »çÀüµî·Ï Àü¹®ÀÇ 70,000 Àü°øÀÇ 50,000 ÇöÀåµî·Ï Àü¹®ÀÇ 80,000 Àü°øÀÇ 60,000 2. º´¸®ÇÐȸ ȸ¿øÀÌ ¾Æ´Ñ °æ¿ì »çÀüµî·Ï Àü¹®ÀÇ 100,000 À¯°ü¾÷ü ¶Ç´Â ´Üü ¼Ò¼Ó ºñȸ¿ø 100,000 Àü°øÀÇ/Á¶±³/´ëÇпø»ý 50,000 ÇöÀåµî·Ï Àü¹®ÀÇ 110,000 À¯°ü¾÷ü ¶Ç´Â ´Üü ¼Ò¼Ó ºñȸ¿ø 110,000 Àü°øÀÇ/Á¶±³/´ëÇпø»ý 60,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 12-01 Àº¸í´ë°´ç 10:00~10:30 Total Mesorectal Excision and Circumferential Resection Margin ±èÀ±È(°æÈñÀÇ´ë) ±³À°½Ã°£ 12-01 Àº¸í´ë°´ç 10:30~11:00 Histologic Type of Colorectal Cancer and Tumor Budding ¼¾È³ª(°æºÏÀÇ´ë) ±³À°½Ã°£ 12-01 Àº¸í´ë°´ç 11:10~11:40 T and N Categories in Colorectal Cancer Staging ÀåÈñÁø(±¹¸³¾Ï¼¾ÅÍ) ±³À°½Ã°£ 12-01 Àº¸í´ë°´ç 11:40~12:10 Histology of Serrated Neoplasia ±èÁ¤È£(¼¿ïÀÇ´ë) ±³À°½Ã°£ 12-01 Àº¸í´ë°´ç 13:20~13:50 Tumor Regression Grading after Preoperative Chemoradiotherapy in Colorectal Cancer °µ¿¿í(À»ÁöÀÇ´ë) ±³À°½Ã°£ 12-01 Àº¸í´ë°´ç 13:50~14:20 Immunoscor ¹èÁ¤¸ð(¼¿ïÀÇ´ë) ±³À°½Ã°£ 12-01 Àº¸í´ë°´ç 14:20~14:50 Immunotherapy in GI Cancer: Role of Biomarker ¹æ¿µÁÖ(¼¿ïÀÇ´ë) ±³À°½Ã°£ 12-01 Àº¸í´ë°´ç 15:20~15:50 Pathologic Interpretation of Immunotherapy Biomarker ±èÇö±â(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 12-01 Àº¸í´ë°´ç 15:50~16:20 Molecular Pathology and Immunohistochemistry of GI Tract ÀÌÇý½Â(¼¿ïÀÇ´ë) ±³À°½Ã°£ 12-01 Àº¸í´ë°´ç 16:20~16:50 Appendiceal Mucinous Neoplasm: an Update on the Diagnosis, Grading and Staging °µ¿¿í(À»ÁöÀÇ´ë)
|